- Policy
- Eun-kyung Jeong “will review limited INN prescriptions”
- by Lee, Jeong-Hwan Jul 28, 2025 06:08am
- Minister of Health and Welfare Eun-Kyung Jeong plans to review a plan to allow limited adoption of international nonproprietary name prescriptions for essential medicines with unstable supply. However, she drew a line on the full introduction of INN prescriptions in place of brand-name prescriptions as a measure to address issues such as
- Company
- Alopecia areata drug Litfulo lands in the Big 5 hospitals
- by Eo, Yun-Ho Jul 28, 2025 06:07am
- Litfulo, a new drug for alopecia areata, may now be prescribed at tertiary hospitals in Korea.. According to industry sources, Pfizer Korea's new Janus kinase (JAK) inhibitor Litfulo (ritlecitinib) has passed review of Drug Committees (DCs) at major medical institutions, including Samsung Medical Center, Seoul National University Hospital
- Policy
- Measures to ban imports of psychotic dietary supplements
- by Lee, Hye-Kyung Jul 28, 2025 06:07am
- The Ministry of Food and Drug Safety (MFDS; Minister, Yu-Kyoung Oh) announced on July 25 that the Ministry is designating '7-Hydroxymitragynine,' an ingredient that is narcotic (antipsychotic), as a prohibited material and ingredient for import into South Korea. This measure was implemented to ban overseas direct purchase of dietary suppleme
- Company
- Mounjaro launch set for August in Korea
- by Whang, byung-woo Jul 25, 2025 06:11am
- The launch date for Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, has been set, signaling the start of full-fledged competition in the obesity treatment market in Korea. Lilly Korea announced on the 23rd that it will launch Mounjaro 2.5mg and 5mg/0.5mL in mid-August for patients with type 2 diabetes and obesity in Korea. Mo
- Company
- Verzenio fails to pass third CDDC review for reimb in KOR
- by Eo, Yun-Ho Jul 25, 2025 06:10am
- Unfortunately, the third time was not the charm. The breast cancer treatment Verzenio is facing difficulties in expanding insurance reimbursement for early breast cancer in Korea. On the 23rd, Lilly Korea’s CDK4/6 inhibitor Verzenio (abemaciclib), which sought to secure reimbursement for its early breast cancer indications, failed to pas
- Policy
- Jeong Eun-kyeong "Pharma·biotech·healthcare powerhouse"
- by Lee, Jeong-Hwan Jul 25, 2025 06:10am
- Jeong Eun-kyeong, inaugurated as the Minister of Health and Welfare, has declared her commitment to driving healthcare reform that wins over the public and the medical community, along with implementing a scientific estimation of the appropriate medical personnel, such as doctors, through the activation of the Estimation Committee for Requir
- Opinion
- [Reporter's View] Denmark's corporate model, Wegovy success
- by Jul 25, 2025 06:10am
- I recently had the opportunity to visit the biotech industry in Denmark. I toured facilities like Novo Nordisk, which rose to stardom with its GLP-1-based obesity treatment Wegovy, as well as LEO Pharma, with its 117-year history, and Lundbeck, a powerhouse in the central nervous system field. What struck me was that all these companies, wit
- Policy
- Daewoong, Kolon enter Ofev generic market at the same price
- by Lee, Tak-Sun Jul 25, 2025 06:09am
- Daewoong Pharmaceutical and Kolon Pharma will additionally enter the generic market for “Ofev Soft Cap (Nintedanib Esylate),” a treatment for chronic fibrotic interstitial lung disease. Competition is expected to intensify in the market with two more generic versions entering the market following Yungjin and Ildong Pharmaceutical’s ent
- Policy
- Reimb criteria established for Roche's DLBCL drug 'Polivy'
- by Lee, Tak-Sun Jul 25, 2025 06:08am
- The reimbursement criteria for Roche Korea's Polivy (polatuzumab vedotin), a treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), have been successfully established by the Health Insurance Review & Assessment Service's (HIRA) Cancer Disease Review Committee (CDRC). This drug, which is garnering attention as the first DL
- Policy
- Eun-Kyung Jeong appointed as new MOHW Minister
- by Lee, Jeong-Hwan Jul 24, 2025 11:38pm
- With the appointment of Eun-kyung&160; Jeong (60, Seoul National University College of Medicine) as Minister of Health and Welfare, efforts to institutionalize and legislate telemedicine, as well as to establish a prescription drug delivery system, are expected to gain momentum. The government will begin establishing specific measures to
